Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jul 31;38(4):e521.
doi: 10.5001/omj.2023.128. eCollection 2023 Jul.

SGLT2 Inhibitors for Cardioprotection

Sulthan Al Rashid  1 , P Elango  2 , Syed Ziaur Rahman  3
Affiliations
Editorial

SGLT2 Inhibitors for Cardioprotection

Sulthan Al Rashid et al. Oman Med J. .
No abstract available

PubMed Disclaimer

References

    1. Briasoulis A, Al Dhaybi O, Bakris GL. SGLT2 inhibitors and mechanisms of hypertension. Curr Cardiol Rep 2018. Jan;20(1):1. 10.1007/s11886-018-0943-5 - DOI - PubMed
    1. Ni L, Yuan C, Chen G, Zhang C, Wu X. SGLT2i: beyond the glucose-lowering effect. Cardiovasc Diabetol 2020. Jun;19(1):98. 10.1186/s12933-020-01071-y - DOI - PMC - PubMed
    1. Mazzali M, Kanbay M, Segal MS, Shafiu M, Jalal D, Feig DI, et al. . Uric acid and hypertension: cause or effect? Curr Rheumatol Rep 2010. Apr;12(2):108-117. 10.1007/s11926-010-0094-1 - DOI - PubMed
    1. Zhang Q, Zhou S, Liu L. Efficacy and safety evaluation of SGLT2i on blood pressure control in patients with type 2 diabetes and hypertension: a new meta-analysis. Diabetol Metab Syndr 2023. Jun;15(1):118. 10.1186/s13098-023-01092-z - DOI - PMC - PubMed
    1. Saucedo-Orozco H, Voorrips SN, Yurista SR, de Boer RA, Westenbrink BD. SGLT2 inhibitors and ketone metabolism in heart failure. J Lipid Atheroscler 2022. Jan;11(1):1-19. 10.12997/jla.2022.11.1.1 - DOI - PMC - PubMed

Publication types

LinkOut - more resources